Live Breaking News & Updates on Single Pills|Page 1

Stay updated with breaking news from Single pills. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed

APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Bruno Wohlschlegel , Thomas Milz , Thomas Zimmermann , Sven Pauly , Monheim Rhein , Group Novartis , Condensed Group Statement Of Financial Position , Condensed Group Statement Of Cash , Condensed Group Statement Of Income , Single Pill , Management Board , Conference Call , Group Statement , Financial Position , Cash Flows , Single Pills ,

EQS-News: APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast

EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/Alliance APONTIS PHARMA enters five-year distribution and mark. ....

Novartis Pharma Gmb , Bruno Wohlschlegel , Monheim Rhein , Sven Pauly , Novartis Pharma Gmbh , Chief Executive Officer , Single Pill , Single Pills ,

APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma me

EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/AllianceAPONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast 05.04.2024 / 10:17 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA enter. ....

Bruno Wohlschlegel , Sven Pauly , Monheim Rhein , Novartis Pharma Gmb , Distribution Services , Novartis Pharma Gmbh , Chief Executive Officer , Single Pill , Single Pills , Corporate News , Regulatory Announcements ,

APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast

EQS-News: APONTIS PHARMA AG

/ Key word: Change in Forecast/Alliance

APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications. ....

Sven Pauly , Monheim Rhein , Novartis Pharma Gmb , Bruno Wohlschlegel , Novartis Pharma Gmbh , Chief Executive Officer , Single Pill , Single Pills ,

APONTIS PHARMA expects profitable growth again in 2024

EQS-News: APONTIS PHARMA AG

/ Key word: Annual Results/Annual Report

APONTIS PHARMA expects profitable growth again in 2024

28.03.2024 / 07:30 CET/CEST

The issuer is. ....

Thomas Zimmermann , Sven Pauly , Monheim Rhein , Thomas Milz , Bruno Wohlschlegel , Condensed Group Income Statement , Condensed Group Statement Of Cash , Single Pill , Chief Executive Officer , Consolidated Statement , Group Statement , Single Pills ,